Novel treatment improves embryo implantation and live birth rates in infertile women undergoing IVF and ICSI

New research has demonstrated the effectiveness of a first-in-class oral, non-hormonal drug in increasing embryo implantation, pregnancy and live birth rates among infertile women who are undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

Facebook Comments